Alderson, Helen V <br/><br/>
FGF-23 and Osteoprotegerin but not Fetuin-A are associated with death and enhance risk prediction in non-dialysis chronic kidney disease stages 3-5.  [electronic resource] 

 -  Nephrology (Carlton, Vic.)  Jul 2016 
 - 566-73 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study 
<br/><br/><label>ISSN: </label>1440-1797 
<br/><br/><label>Standard No.: </label>10.1111/nep.12664  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Area Under Curve<br/>Biomarkers--blood<br/>Cardiovascular Diseases--etiology<br/>Disease Progression<br/>Female<br/>Fibroblast Growth Factor-23<br/>Fibroblast Growth Factors--blood<br/>Humans<br/>Kidney Failure, Chronic--etiology<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Odds Ratio<br/>Osteoprotegerin--blood<br/>Predictive Value of Tests<br/>Prognosis<br/>Proportional Hazards Models<br/>Prospective Studies<br/>ROC Curve<br/>Renal Dialysis<br/>Renal Insufficiency, Chronic--blood<br/>Risk Assessment<br/>Risk Factors<br/>Time Factors<br/>alpha-2-HS-Glycoprotein--analysis